Across 73,592 matched pairs, starting a GLP-1 drug instead of a DPP-4 inhibitor was linked to slower frailty and a 13% lower fall rate.
Recap by typeshit. Post by Professor Kamlesh Khunti on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The 80-week Lancet study enrolled 1,152 adults. Placebo lost 5.1%, and nearly half on the 12 mg dose lost at least 20%. The drug is still investigational.
The bid covers adults with BMI 30 or more, heart patients and teens. Korea's customs service caught 5,030 illegal obesity drug imports this year.
Loading…